These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20335732)

  • 1. Immortal time bias in critical care research.
    Funk GC; Lindner G
    Crit Care Med; 2010 Apr; 38(4):1237. PubMed ID: 20335732
    [No Abstract]   [Full Text] [Related]  

  • 2. Immortal time bias in critical care.
    Shintani AK; Girard TD; Ely EW
    Crit Care Med; 2010 Apr; 38(4):1229. PubMed ID: 20335718
    [No Abstract]   [Full Text] [Related]  

  • 3. When is simple too simple? Immortal time bias in critical care.
    Linde-Zwirble W
    Crit Care Med; 2009 Nov; 37(11):2990-1. PubMed ID: 19851142
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding immortal time bias in observational cohort studies.
    Ho AM; Dion PW; Ng CS; Karmakar MK
    Anaesthesia; 2013 Feb; 68(2):126-30. PubMed ID: 23298346
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival analysis of time-to-event data in respiratory health research studies.
    Kasza J; Wraith D; Lamb K; Wolfe R
    Respirology; 2014 May; 19(4):483-92. PubMed ID: 24689901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies.
    Liu J; Weinhandl ED; Gilbertson DT; Collins AJ; St Peter WL
    Kidney Int; 2012 Feb; 81(4):341-50. PubMed ID: 22089946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.
    Daniel S; Koren G; Lunenfeld E; Levy A
    Am J Obstet Gynecol; 2015 Mar; 212(3):307.e1-6. PubMed ID: 25265406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of postoperative mortality: pattern of use of β-blockade, bias, or both?
    van Klei WA; Peelen LM; Buhre WF
    Anesthesiology; 2011 May; 114(5):1246-7; author reply 1248-9. PubMed ID: 21521975
    [No Abstract]   [Full Text] [Related]  

  • 9. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients.
    Shehabi Y; Riker RR; Bokesch PM; Wisemandle W; Shintani A; Ely EW;
    Crit Care Med; 2010 Dec; 38(12):2311-8. PubMed ID: 20838332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hazard of Non-proportional Hazards in Time to Event Analysis.
    Meuli L; Kuemmerli C
    Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):495-498. PubMed ID: 34362630
    [No Abstract]   [Full Text] [Related]  

  • 11. Delirium after surgical and transcatheter aortic valve replacement is associated with increased mortality.
    Maniar HS; Lindman BR; Escallier K; Avidan M; Novak E; Melby SJ; Damiano MS; Lasala J; Quader N; Rao RS; Lawton J; Moon MR; Helsten D; Pasque MK; Damiano RJ; Zajarias A
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):815-823.e2. PubMed ID: 26774165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immortal time bias in pharmaco-epidemiology.
    Suissa S
    Am J Epidemiol; 2008 Feb; 167(4):492-9. PubMed ID: 18056625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Nadir PSA: Of Popes and PSA--The Immortality Bias.
    Johnson SB; Jackson WC; Murgic J; Feng FY; Hamstra DA
    Am J Clin Oncol; 2015 Oct; 38(5):465-71. PubMed ID: 24064749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortal time bias in observational studies of drug effects in pregnancy.
    Matok I; Azoulay L; Yin H; Suissa S
    Birth Defects Res A Clin Mol Teratol; 2014 Sep; 100(9):658-62. PubMed ID: 24985740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Predictive Factors, and Effect of Delirium After Transcatheter Aortic Valve Replacement.
    Abawi M; Nijhoff F; Agostoni P; Emmelot-Vonk MH; de Vries R; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2016 Jan; 9(2):160-8. PubMed ID: 26793958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis in clinical trials: old tools or new techniques.
    Paoletti X; Asselain B
    Surg Oncol; 2010 Jun; 19(2):55-8; discussion 61. PubMed ID: 20167477
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of immortal person-time when outcomes are nonfatal.
    Liang C; Seeger JD; Dore DD
    Ann Epidemiol; 2016 Mar; 26(3):212-7. PubMed ID: 26847051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias.
    Gardarsdottir H; Egberts TC; Stolker JJ; Heerdink ER
    Am J Epidemiol; 2009 Aug; 170(3):280-5. PubMed ID: 19498074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Analysis.
    Gogtay NJ; Thatte UM
    J Assoc Physicians India; 2017 May; 65(5):80-84. PubMed ID: 28598052
    [No Abstract]   [Full Text] [Related]  

  • 20. Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model.
    Demissie S; LaValley MP; Horton NJ; Glynn RJ; Cupples LA
    Stat Med; 2003 Feb; 22(4):545-57. PubMed ID: 12590413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.